Evidence based medicine and justice: a framework for looking at the impact of EBM upon vulnerable or disadvantaged groups
Open Access
- 1 April 2004
- journal article
- review article
- Published by BMJ in Journal of Medical Ethics
- Vol. 30 (2), 141-145
- https://doi.org/10.1136/jme.2003.007062
Abstract
This article examines the implicit promises of fairness in evidence based medicine (EBM), namely to avoid discrimination through objective processes, and to distribute effective treatments fairly. The relationship between EBM and vulnerable groups (such as those disadvantaged by virtue of poverty, ethnicity, age, gender, mental health problems or similar) is examined. Several aspects of EBM are explored: the way evidence is created (commissioning and design of, and participation in research), and the way evidence is applied in clinical care and health policy. This analysis suggests that EBM turns our attention away from social and cultural factors that influence health and focuses on a narrow biomedical and individualistic model of health. Those with the greatest burden of ill health are left disenfranchised, as there is little research that is relevant to them, there is poor access to treatments, and attention is diverted away from activities that might have a much greater impact on their health.Keywords
This publication has 24 references indexed in Scilit:
- SERMs, Ethnicity, and Clinical TrialsAnnals of the New York Academy of Sciences, 2006
- Medical journals: evidence of bias against the diseases of povertyThe Lancet, 2003
- Are large clinical trials in rapidly lethal diseases usually unethical?The Lancet, 2003
- Selection and description of cancer clinical trials participants—Science or happenstance?Cancer, 2002
- Representation of the Elderly, Women, and Minorities in Heart Failure Clinical TrialsArchives of Internal Medicine, 2002
- Evidence‐based medicine in practice: limiting or facilitating patient choice?Health Expectations, 2002
- Systematic reviews in health care: Investigating and dealing with publication and other biases in meta-analysisBMJ, 2001
- Relation of Race and Sex to the Use of Reperfusion Therapy in Medicare Beneficiaries with Acute Myocardial InfarctionThe New England Journal of Medicine, 2000
- Influence of Race or Ethnicity on Pharmacokinetics of DrugsJournal of Pharmaceutical Sciences, 1997
- Racial, Ethnic and Gender Differences in Response to MedicinesDrug Metabolism and Drug Interactions, 1995